VHL and papillary renal cell carcinoma: In papillary renal cell carcinoma, 3p deletions (Figure 4D–4F) but not VHL mutations (Figure 4A–4C) were significantly associated with both relapse-free survival and cancer specific death (p < 0.05, each).